SEC Filing Details
Document Details
Form
Filing Date
May 13, 2024
Document Date
March 31, 2024
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
Aerovate Therapeutics, Inc.
Issuer
Aerovate Therapeutics, Inc.